Sandercock Colin (CIK 0001724870)

Latest company ownership

CUE - Cue Biopharma, Inc.
Role: SVP, General Counsel and Sec
Shares held
60,000
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 5, 2020 Aug 10, 2020 Cue Biopharma, Inc. SVP, General Counsel and Sec Sell 7.5 -13,374 -43.85% ✓ $267.5K
Aug 5, 2020 Aug 7, 2020 Cue Biopharma, Inc. SVP, General Counsel and Sec Sell 7.5 -13,274 -43.67% ✓ $265.5K
Aug 3, 2020 Aug 5, 2020 Cue Biopharma, Inc. SVP, General Counsel and Sec Sell 20.0 -6,626 -16.21% ✓ $132.5K
Jun 7, 2019 Feb 24, 2020 Cue Biopharma, Inc. SVP, General Counsel and Sec Buy 95.0 +15,125 756.25% ✗ $119.4K
Jun 6, 2019 Jun 10, 2019 Cue Biopharma, Inc. SVP, General Counsel and Sec Buy 95.0 +16,938 100.00% ✗ $132.7K